Prosecution Insights
Last updated: October 25, 2026

Retriever Medical Inc.

Technology area: Chemistry & Materials

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Retriever Medical Inc. has 1 pending office action within the Chemistry & Materials technology area. This action is being reviewed by 1 distinct examiner in 1 distinct art unit. This data points to a highly focused prosecution effort, where the company's current intellectual property interests are concentrated in a single chemical or material science specialty.

KRISHNAN S MENON is the busiest examiner for the company, currently handling 1 pending office action. This 1 busiest examiner pending action matches the total number of pending office actions for the portfolio. For the practitioner, this indicates that the prosecution strategy is entirely dependent on the interactions with this specific examiner. The use of 1 distinct art unit suggests that the company is not currently navigating the varied requirements of different examination groups within the USPTO's chemistry divisions.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
0
Medium (0%)
1
Easy (100%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Double-patenting only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
MENON, KRISHNAN S 1 59.7% +11.3%

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18680305 Systems, Apparatus and Methods for Processing Autologous Blood for Reinfusion into a Patient MENON, KRISHNAN S —

Top Art Units

Art UnitApps
1771 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18680305 Systems, Apparatus and Methods for Processing Autologous Blood for Reinfusion into a Patient MENON, KRISHNAN S 1771 DP Non-Final OA — Pending May 31, 2024

Managing Retriever Medical Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Retriever Medical Inc. have?

Retriever Medical Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Retriever Medical Inc. applications?

Krishnan S Menon has the most, with 1 of Retriever Medical Inc.'s pending office actions.

What technology area are Retriever Medical Inc.'s patent applications in?

Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month